Dr Reddys Laboratories (RDY) Return on Invested Capital [ROIC] (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Return on Invested Capital [ROIC] of 12.85% for the quarter ended Jun 30, 2026, up 2.37 percentage points from 10.48% a year earlier but down 2.00 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Dr Reddys Laboratories' Return on Invested Capital [ROIC] came in at 8.90%, down 6.79 percentage points from the prior year.
- Annual Return on Invested Capital [ROIC] shows a five-year change of +0.44 percentage points (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Return on Invested Capital [ROIC] was 15.70% in the year ended Mar 31, 2025 (-3.02 pp), 18.71% in the year ended Mar 31, 2024 (+1.65 pp), 17.06% in the year ended Mar 31, 2023 (+7.16 pp) and 9.90% in the year ended Mar 31, 2022 (+1.44 pp).
- Quarterly Return on Invested Capital [ROIC] has run from a low of 7.91% in the quarter ended Sep 30, 2024 to a high of 18.74% in the quarter ended Jun 30, 2023 over five years.
- On a year-over-year basis, Return on Invested Capital [ROIC] increased in five of the last eight quarters, with an average year-over-year change of -0.40 percentage points.
- The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was the quarter ended Jun 30, 2023, with a gain of 9.89 percentage points; the weakest was the quarter ended Sep 30, 2024, with a drop of 10.52 percentage points.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 14.85% (quarter ended Mar 31, 2026), 10.48% (quarter ended Dec 31, 2025) and 10.17% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 12.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.85% |
| Mar 31, 2026 | 14.85% |
| Dec 31, 2025 | 10.48% |
| Sep 30, 2025 | 10.17% |
| Jun 30, 2025 | 10.48% |
| Mar 31, 2025 | 10.93% |
| Dec 31, 2024 | 11.20% |
| Sep 30, 2024 | 7.91% |
| Jun 30, 2024 | 8.95% |
| Mar 31, 2024 | 9.51% |
| Dec 31, 2023 | 14.61% |
| Sep 30, 2023 | 18.43% |
| Jun 30, 2023 | 18.74% |
| Mar 31, 2023 | 18.63% |
| Dec 31, 2022 | 13.55% |
| Sep 30, 2022 | 11.17% |
| Jun 30, 2022 | 8.85% |
| Mar 31, 2022 | 8.93% |
| Dec 31, 2021 | 11.30% |
| Sep 30, 2021 | 12.31% |
API Access
Dr Reddys Laboratories Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();